JC Decaux

Modelling (again) the impact of COVID-19

26/03/20 -"We have revised our forecasts downwards again, after the group indicated its Q1 guidance (-10% organic) is no longer valid and that Q2 will be worse, with the COVID-19 crisis spreading in Europe and ..."

PDF page sample
Pages
48
Language
English
Published on
26/03/20
Download
You may also be interested by these reports :
18/11/25
Your obvious AI quality call (II)
17/11/25
Informa unveiled an attractively refined guidance for the 2025-2028 period for its CMD, which is broadly in line with our estimates. There are no ...
14/11/25
MFE launched an offer in March at €5.75 per share, later increasing it to €8 (€4.45 in cash and the remainder in MFE shares). On 4 September, MFE ...
14/11/25
Wolters Kluwer announced a relatively small acquisition to reinforce its GenAI capabilities in legal. We think this is a smart acquisition as the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO